Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001132

Drug Information
NameSuccinylcholine    
Synonymstrimethyl-[2-[4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl]oxyethyl]azanium; DB00202; 306-40-1; Lysthenon; 2ha6; CHEBI:45652; Choline, succinate (ester); CHEMBL703; AC1L1K2T; trimethyl-[2-[4-oxo-4-(2-trimethylazaniumylethoxy)butanoyl]oxyethyl]azanium diio; Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl-; C07546; Suxamethonium; ST50437287; Choline, succinyl-; HMS2090P14; Dicholine succinate; NCGC00162336-01; Quelicin; Ditilin; 4-04-00-01451 (Beilstein Handbook Reference); Ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy))bis(N,N,N-trimethyl)-; C14H30N2O4; Succinic acid, diester with choline; 2,2'-[(1,4-DIOXOBUTANE-1,4-DIYL)BIS(OXY)]BIS(N,N,N-TRIMETHYLETHANAMINIUM); Succinic acid, diester with choline chloride; STK177290; Lopac-S-8251; LS-53328; L000926; succinylcholine; 55-94-7 (dibromide); Diacetylcholine; Ditiline; Succinylbischoline; Succinyldicholine; UNII-J2R869A8YF; Lopac0_001080; InChI=1/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2; Succinocholine; CID5314; Succinyl choline; HSDB 3254; MolPort-002-964-486; NCGC00015971-01; ZINC01530820; AXOIZCJOOAYSMI-UHFFFAOYSA-; Succinoylcholine; BRN 1805311; 71-27-2 (dichloride); Anectine; Sucostrin; SCK; 2ha2; 541-19-5 (diiodide); Succicuran; Choline, succinate (2:1) (ester); Listenon; NCGC00015971-03    
Trade NameAnectine; Scoline    
IndicationSpasms, PainApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnalgesics    
CAS NumberCAS 306-40-1
FormularC14H30N2O4    
PubChem Compound IDCID 5314.    
PubChem Substance IDSID 9749.    
ChEBI45652;    
SuperDrug ATC IDM03AB01;    
SuperDrug CAS ID000306401;    
TargetMuscarinic acetylcholine receptor M3Antagonist[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 008453 To Reference
Ref 2The involvement of histaminic and muscarinic receptors in the bronchoconstriction induced by myorelaxant administration in sensitized rabbits. Anesth Analg. 2008 Dec;107(6):1899-906. To Reference
Ref 3Anesthesiology. 1998 Mar;88(3):744-50.Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543